Document is current

Any future updates will be listed below

Correction: Drug development for rare diseases: a case for patient-centricity, equity, and access to clinical trials

Crossref DOI link: https://doi.org/10.1007/s44162-025-00101-1

Published Online: 2025-06-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark